CHIEF FINANCIAL OFFICER
Tue, Nov 19, 2024
Nov 19
exercised or converted securities in ACLX
3,000 shares @ $0.00
Decreased holdings by -3.70%
Net across this filing: +70.40% (+1,239 shares)
Option Exercise
Sale tied to a same-time option exercise
ACLXArcellx, Inc.
Health CareBiotechnology